WT
KRSA

WHI Trust’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

WHI Trust’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244 Hold
10
– – ﹤0.01% 59
2026
Q1 		$112 Hold
10
– – ﹤0.01% 87
2025
Q4 		$91 Buy
+10
New +$125 ﹤0.01% 94

Other funds holding KRSA

KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

WHI Trust's KRSA Position: Q2 2026 in Review

WHI Trust held its Korsana Biosciences, Inc. Common Stock (KRSA) position steady in Q2 2026 at 10 shares worth $244. The position accounts for ﹤0.01% of the portfolio, ranked #59.

WHI Trust first reported a position in KRSA in Q4 2025 and has held it in 3 quarters since. 21 funds tracked by Wall St. Rank hold KRSA as of Q2 2026.

  • WHI Trust held 10 shares of Korsana Biosciences, Inc. Common Stock worth $244 as of Q2 2026.
  • WHI Trust left its Korsana Biosciences, Inc. Common Stock share count unchanged in Q2 2026.
  • Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of WHI Trust's portfolio in Q2 2026, its #59 holding.
  • WHI Trust first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2025 and has held it in 3 quarters since.
  • 21 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2026.

Based on WHI Trust's 13F filing for Q2 2026, filed 11 Aug 2026.